According to a recently published analytical report by Future Market Insights, the global Advanced Therapy Medicinal Products Market had US$ 8.7 billion in sales in 2021. The market is anticipated to grow at a 15% CAGR from 2022 to 2032, reaching a US$ 39 billion valuation. The market segment expected to generate the highest revenue …
Category Archives: Healthcare Trends
Korea Swine Vaccine Market is projected to reach a massive value of US$ 2.8 billion by 2032 at a CAGR of around 6.0%
Swine Vaccine Market is expected to expand at a CAGR of around 6.0% to 7.0% CAGR between 2022 and 2032, as per Future Market Insights’ latest industry analysis. With the global swine vaccine industry anticipated to reach a massive value of US$ 2.8 billion by 2032, Korea will hold a significant share of the global …
Amyotrophic Lateral Sclerosis Market is expected to reach US$ 1332.22 Million by 2033 at a CAGR of 6%
The global Amyotrophic Lateral Sclerosis Market is estimated to generate a market value of US$ 743.90 Million in 2023 and a market value of US$ 1332.22 Million by achieving a CAGR of 6% between 2023 and 2033. Amyotrophic Lateral Sclerosis market growth can be attributable to an aging population, increased awareness of ALS, and an increasing incidence rate. Amyotrophic Lateral Sclerosis (ALS) market …
Europe Non-Small Cell Lung Cancer Market is expected to grow at a CAGR of 7% during the assessment period 2023 to 2033
A recently published study by FMI expects the global Non-Small Cell Lung Cancer Market to augment at a 7.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 20 Billion is expected for the market. From 2018 to 2022, the industry experienced noteworthy growth, registering a value CAGR of …
Brachytherapy Market | Eckert and Ziegler Group, Isoray Inc., Elekta AB, Theragenics Corp. | By 2032
According to Future Market Insights’ recently published Brachytherapy Market analysis report, the market’s global sales in 2021 were estimated to be US$ 892.9 Mn. The market is anticipated to reach a value of US$ 2.1 Bn by 2032 with a CAGR of 8.3% from 2022 to 2032. The highest revenue-generating segment is anticipated to be …
North America is expected to have the most opportunistic Juvenile Idiopathic Arthritis Diagnostic Market, growing at a CAGR of 3.7% by 2032
The global Juvenile Idiopathic Arthritis Diagnostic Market was worth US$ 5.81 Bn in the year 2022 and is expected to reach US$ 8.6 Bn by the year 2032 at a CAGR of 4% between 2022 and 2032. Juvenile idiopathic arthritis comes across as a disease causing pain as well as inflammation in the joints with …
Hair Restoration Market is expected to rise at a CAGR of around 18.2% between 2022 and 2032 | FMI
According to Future Market Insights’ newly released Hair Restoration market analysis report, global sales of Hair Restoration in 2021 are expected to be US$ 4.9 billion. The projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth, with a CAGR of 18.2%. Follicular Unit Extraction is expected to …
Depression Treatment Market is expected to reach a valuation of US$ 16.8 Billion by 2032 | FMI Study
The global Depression Treatment Market is predicted to reach a valuation of US$ 16.8 Billion by 2032, with the market growing at a moderate CAGR of 5.2% from 2022 to 2032. Valued at US$ 9.7 Billion in 2021, the target market is expected to reach an estimated US$ 10.1 Billion in 2022. Different factors like …
Prinzmetal Angina Therapeutics Market is expected to be worth US$ 17.2 billion by 2033 | FMI
The global Prinzmetal Angina Therapeutics Market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of …
Intestinal Fistula Treatment Market Value to reach a valuation of US$ 46.82 Billion by 2033 | FMI Report
The global Intestinal Fistula Treatment Market is expected to be valued at US$ 26.64 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for intestinal fistula treatment is projected to grow at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 46.82 Billion by 2033. Factors such as …